Moreover, it has been shown that O-6-sialylation of integrin β1 N-glycans, mediated by ST6Gal-I, completely blocked its recognition by Gal-3; conversely O-3-sialylation did not affect Gal-3 recognition in gastric cancer (108, 109). This evidence concerns the gene LGALS3 and gastric cancer.